DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01434576 (ClinicalTrials.gov)	December 2011	1/9/2011	Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis	A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics and Safety of HGS1025, a Human Monoclonal Anti-CCR5 Antibody, in Subjects With Ulcerative Colitis	Ulcerative Colitis	Biological: HGS1025;Drug: Placebo	Human Genome Sciences Inc.	NULL	Withdrawn	18 Years	N/A	Both	0	Phase 1	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01434576
(ClinicalTrials.gov)

December 2011

1/9/2011

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics and Safety of HGS1025, a Human Monoclonal Anti-CCR5 Antibody, in Subjects With Ulcerative Colitis

Ulcerative Colitis

Biological: HGS1025;Drug: Placebo

Human Genome Sciences Inc.

NULL

Withdrawn

18 Years

N/A

Both

Phase 1

NULL